Why evidence-based medicine failed in patient care and medicine-based evidence will succeed

Journal of Clinical Epidemiology

Volumn 84, Issue , 2017, Pages 14-17

  Horwitz, Ralph I ^a   Singer, Burton H ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Evidence based medicine; Medicine based evidence; Personalized medicine

Indexed keywords

ARTICLE; CLINICAL MEDICINE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL CARE; MEDICINE BASED EVIDENCE; PATIENT CARE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL ENVIRONMENT; MEDICAL RESEARCH; METHODOLOGY; PROCEDURES;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT CARE; RESEARCH DESIGN;

EID: 85019918157     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2017.02.003     Document Type: Article

References (15)

1. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council Investigation. Br Med J, 2, 1948, 769.
2. Horwitz, R.I., Singer, B.H., Makuch, R.W., Viscoli, C.M., Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. J Clin Epidemiol 49 (1996), 395–400.
3. Rawlins, M.D., Harveian Oration. De Testimonia on the evidence for decisions about the use of therapeutic interventions. Lancet 372 (2008), 2152–2161.
4. Bartlett, C., Doyal, L., Ebrahim, S., Davey, P., Bachmann, M., Egger, M., et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess, 9, 2005, 38.
5. Malmstrom, K., Rodriguez-Gomez, G., Guerra, J., Villaran, C., Piñeiro, A., Wei, L.X., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Ann Intern Med 130 (1999), 487–495.
6. Price, D., Musgrave, M.D., Shepstone, L., Hillyer, E.V., Simms, E., Gilbert, R.T., et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 364 (2011), 1695–1707.
7. Kernan, W.N., Viscoli, C.M., Brass, L.M., Broderick, J.P., Brott, T., Feldmann, E., et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 343 (2000), 1826–1832.
8. Graham, D.J., Green, L., Senior, J.R., Nourjah, P., Troglitazone-induced liver failure: a case study. Am J Med 114 (2003), 299–306.
9. Concato, J., Shah, N., Horwitz, R.I., Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342 (2000), 1887–1892.
10. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, et al. Grading the strength of a body of evidence when comparing medical interventions. In: Agency for Healthcare Research and Quality Methods Grade for Comparative Effectiveness Reviews. [posted July 2009]. Available at http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=60.
11. Hill, A.B., Reflections on controlled trial. Ann Rheum Dis, 25, 1966, 107.
12. Benson, K., Hartz, A.J., A comparison of observational studies and randomized, controlled trials. N Engl J Med 342 (2000), 1878–1886.
13. Stohl, W., Hilbert, D.M., The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol 30 (2012), 69–77.
14. Urowitz, M.B., Gladman, D.D., Tom, B.D., Ibañez, D., Farewell, V.T., Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 35 (2008), 2152–2158.
15. Knottnerus, J.A., Dinant, G.J., Medicine based evidence, a prerequisite for evidence based medicine. BMJ 315 (1997), 1109–1110.